Wuhan, China

Guofan Xie


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guofan Xie: Innovator in Antitumor and Antibacterial Agents

Introduction

Guofan Xie is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor and antibacterial properties. His innovative work has led to the creation of a unique method for preparing specific chemical derivatives.

Latest Patents

Guofan Xie holds a patent for "5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same." This patent describes a method for preparing 5,6-dimethylxanthone-4-acetic acid (DMXAA) and its derivatives. The derivatives are characterized by a specific formula, where R represents various substitutes that can enhance the compound's effectiveness. The invention also includes a pharmaceutical composition that utilizes these derivatives as excellent antitumor and antibacterial agents. He has 1 patent to his name.

Career Highlights

Guofan Xie is associated with Grand Pharma (China) Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His research focuses on developing compounds that can significantly impact the treatment of various diseases.

Collaborations

Guofan has collaborated with notable colleagues such as Wei Li and Jianzhong Zhou. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Guofan Xie's contributions to the field of pharmaceuticals, particularly through his patented methods and compounds, highlight his role as an innovator in the industry. His work continues to pave the way for advancements in antitumor and antibacterial treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…